MiR-29 is decreased in kidney, lung, liver, and myocardial fibrosis and it is important to fibrosis molecules, such as collagen I and III, insulin-like-growth factor-1 (IGF-1), and connective tissue growth factor (CTGF) [17, 20–27]. The gene discussed is CCN2; the disease is Myocardial fibrosis.